This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alexion Pharmaceuticals Inc (ALXN)

NASDAQ: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 0.00 656.91M 252.90M 254.82M
Operating Gains/Losses n.a. 0.00 764.00K -2.69M
Extraordinary Gains / Losses n.a. 0.00 0.00 0.00
(Increase) Decrease In Receivables n.a. -28.14M -116.44M -72.87M
(Increase) Decrease in Inventories n.a. -66.81M 126.00K -6.26M
(Increase) Decrease In Other Current Assets n.a. 0.00 0.00 0.00
(Decrease) Increase In Payables n.a. 264.57M 136.64M 61.72M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital n.a. 6.20M 23.48M 13.17M
Other Non-Cash Items n.a. -82.82M 115.01M 84.72M
Net Cash From Continuing Operations n.a. 640.08M 497.35M 410.61M
Net Cash From Discontinued Operations n.a. 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0.00 640.08M 497.35M 410.61M
Sale of Property, Plant & Equipment n.a. 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments n.a. 619.45M 60.92M 0.00
Purchases of Property, Plant & Equipment 0.00 -136.65M -29.33M -21.85M
Acquisitions n.a. 0.00 0.00 -605.74M
Purchases of Short-Term Investments n.a. -664.23M -1.05B 0.00
Other Cash from Investing Activities 0.00 -38.01M -9.31M -4.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities 0.00 -222.87M -1.03B -627.59M
Issuance of Debt 0.00 0.00 0.00 355.00M
Cash Used for Financing Activities
Issuance of Capital Stock n.a. 114.35M 71.28M 528.65M
Repayment of Long-Term Debt 0.00 -55.50M -36.00M -206.00M
Repurchase of Capital Stock 0.00 -302.60M -66.14M -11.55M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net n.a. 250.88M 102.49M 279.00K
Net Cash From Financing Activities 0.00 7.13M 71.64M 666.38M
Effect of Exchange Rate Changes 0.00 -10.19M -1.49M -768.00K
Net Change in Cash & Cash Equivalents 0.00 414.14M -459.64M 448.64M
ALXN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ALXN Alexion Pharmaceuticals Inc

Chart of ALXN

Analysts Ratings for ALXN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 11 11 11
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ALXN ANALYST REPORT

ALXN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs